Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2023. Go to the latest filing (Q3 2026)

24.3B USDQ2 2023
Total value of stock positions
24.3B USD
Positions
85
Share of the ten largest
37.4%

The ten largest positions Q2 2023

  1. Visa Inc. 7.0%▲ +8.8%
  2. Danaher Corporation 4.2%new
  3. Api Group Corp 3.8%▲ +0.3%
  4. Philip Morris International 3.6%new
  5. UnitedHealth Group 3.5%▼ −14.6%
  6. GE Aerospace 3.2%▼ −17.1%
  7. Roivant Sciences Ltd 3.1%▼ −14.7%
  8. Meta Platforms 3.1%▼ −19.7%
  9. Fortive 3.0%▲ +54.4%
  10. Workday, Inc. 2.8%▲ +373.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2023

Positions Q2 2023 per 13F filing, 27 of 27
Symbol Weight Shares Reported value Change Held since
MSFT Microsoft 1.7% 1,202,051 409.3M USD +14.8% increased Q2 2016 29 quarters
V Visa Inc. 7.0% 7,140,286 1.7B USD +8.8% increased Q3 2016 28 quarters
FTV Fortive 3.0% 9,798,229 732.6M USD +54.4% increased Q3 2019 16 quarters
Api Group Corp 3.8% 34,199,532 932.3M USD +0.3% increased Q2 2020 13 quarters
4D Molecular Therapeutics In 0.4% 4,787,914 86.5M USD +21.6% increased Q4 2020 11 quarters
AMP Ameriprise Financial 1.5% 1,124,103 373.4M USD +19.5% increased Q1 2021 10 quarters
Zai Lab Ltd 0.3% 2,629,445 72.9M USD +12.8% increased Q1 2021 10 quarters
Edgewise Therapeutics Inc 0.2% 5,943,261 46.1M USD +21.1% increased Q1 2021 10 quarters
Day One Biopharmaceuticals I 0.1% 2,558,563 30.5M USD +64.2% increased Q2 2021 9 quarters
Hdfc Bank Ltd 2.7% 9,312,208 649.1M USD +12.4% increased Q3 2021 8 quarters
Biomarin Pharmaceutical Inc 1.5% 4,156,785 360.3M USD +91.7% increased Q4 2021 7 quarters
IFF International Flavors & Fragrances 1.2% 3,569,966 284.1M USD +339.3% increased Q4 2021 7 quarters
MA Mastercard 1.6% 1,012,725 398.3M USD +27.1% increased Q1 2022 6 quarters
Unum Group 1.0% 5,271,387 251.4M USD +23.9% increased Q1 2022 6 quarters
MU Micron Technology 1.1% 4,424,339 279.2M USD +54.9% increased Q2 2022 5 quarters
CDNS Cadence Design Systems 1.7% 1,750,247 410.5M USD +42.8% increased Q3 2022 4 quarters
Valvoline Inc 1.2% 7,682,814 288.2M USD +3.8% increased Q3 2022 4 quarters
Newamsterdam Pharma Company 0.3% 6,524,565 77.6M USD +66.6% increased Q4 2022 3 quarters
WDAY Workday, Inc. 2.8% 3,038,619 686.4M USD +373.0% increased Q1 2023 2 quarters
SHW Sherwin-Williams 2.5% 2,274,718 604.0M USD +1.0% increased Q1 2023 2 quarters
Coupang Inc 1.1% 15,315,205 266.5M USD +106.4% increased Q1 2023 2 quarters
SNPS Synopsys 0.6% 310,608 135.2M USD +51.5% increased Q1 2023 2 quarters
CL Colgate-Palmolive 0.4% 1,238,533 95.4M USD +87.5% increased Q1 2023 2 quarters
RIVN Rivian Automotive 0.4% 5,433,046 90.5M USD +3.5% increased Q1 2023 2 quarters
Cnh Indl N V 0.3% 4,766,168 68.6M USD +68.6% increased Q1 2023 2 quarters
DELL Dell Technologies 0.3% 1,215,208 65.8M USD +11.0% increased Q1 2023 2 quarters
Viking Therapeutics Inc 0.2% 3,544,506 57.5M USD +81.3% increased Q1 2023 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 86.4M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 86.4M USD

Breakdown by sector

  • Technology 14.8%
  • Health Care 13.0%
  • Financials 12.6%
  • Industrials 9.4%
  • Consumer Discretionary 5.4%
  • Consumer Staples 4.4%
  • Communication Services 4.2%
  • Materials 4.2%
  • Real Estate 1.5%
  • Utilities 0.4%
  • not in our coverage 30.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close